Cargando…
Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
Autores principales: | Erfani, Parsa, Bates, Michael, Garcia-Gonzalez, Pat, Milner, Dan A., Rebbeck, Timothy R., Ruhangaza, Deogratias, Shulman, Lawrence N., Fadelu, Temidayo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812500/ https://www.ncbi.nlm.nih.gov/pubmed/36252158 http://dx.doi.org/10.1200/GO.22.00182 |
Ejemplares similares
-
Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert(®) mRNA expression assay
por: Erfani, Parsa, et al.
Publicado: (2023) -
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
por: Fadelu, Temidayo A., et al.
Publicado: (2022) -
Harmonization of the Essentials: Matching Diagnostics to Treatments for Global Oncology
por: LeJeune, Analise, et al.
Publicado: (2020) -
Commentary: Leveraging Edge Computing Technology for Digital Pathology
por: Yousif, Mustafa, et al.
Publicado: (2021) -
Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort
por: Fadelu, Temidayo, et al.
Publicado: (2020)